News Releases

Updates every hour. Last Updated: 24-Jun-2026 02:16 ET (24-Jun-2026 06:16 GMT/UTC)

21-Jan-2026

The Ralph Lauren Corporate Foundation to open fourth center in the US with the University of Chicago Medicine Comprehensive Cancer Center

University of Chicago Medical Center
Grant and Award Announcement

UChicago Medicine Ralph Lauren Center to provide greater access to high-quality cancer care and preventative services for Chicago’s South Side and Southland communities

21-Jan-2026

 

SPARK Microgravity announces plans for Europe’s first commercial cancer lab in space at Frontiers Science House in Davos

Frontiers
Business Announcement

At Frontiers Science House, SPARK Microgravity GmbH revealed plans to build Europe’s first dedicated commercial orbital cancer lab. The lab will accelerate the path from discovery to therapy. In microgravity, researchers can run experiments that are impossible on Earth – including 3D tumor growth and revealing new drug targets.

21-Jan-2026

 

Engineered nanobodies improved respiratory defenses in preclinical study

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

In a multi-institutional study published today in Nature Nanotechnology, researchers from The University of Texas MD Anderson Cancer Center reported that engineered bispecific nanobodies successfully strengthened mucosal defenses in the respiratory tract, improving protection against influenza infection and reducing SARS-CoV-2 transmission in vivo.

Journal

Nature Nanotechnology

21-Jan-2026

A study analyses which lung cancer subtypes are associated with different air pollutants

Barcelona Institute for Global Health (ISGlobal)
Peer-Reviewed Publication

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by “la Caixa” Foundation, in collaboration with the American Cancer Society (ACS), analysed the relationship between different air pollutants and the main subtypes of lung cancer. 

Journal

Environmental Pollution

Funder

American Cancer Society, Ministerio de Ciencia, European Social Fund, Generalitat de Catalunya

20-Jan-2026

 

Plasma-guided mitotane for the treatment of adrenocortical carcinoma: adjuvant care to advanced disease

Shanghai Jiao Tong University Journal Center
Peer-Reviewed Publication

Mitotane is the only FDA- and EMA-approved drug for adrenocortical carcinoma, acting through disruption of cholesterol metabolism and steroidogenic enzymes. This review summarizes its mechanisms, clinical efficacy, therapeutic drug monitoring, and adverse effect management, emphasizing the importance of the therapeutic window (14–20 mg/L) for optimized clinical outcomes.

Journal

LabMed Discovery

20-Jan-2026

McGill researchers identify a range of unexpected chemical contaminants in human milk

McGill University
Peer-Reviewed Publication

An interdisciplinary team including researchers at McGill University has found a range of unexpected chemical contaminants in human milk samples from Canada and South Africa. The chemicals include traces of pesticides, antimicrobials and additives used in plastics and personal-care products. The findings were published across five papers.

Funder

Canada Foundation for Innovation, Canadian Institutes of Health Research, Canada Research Chairs

20-Jan-2026

In Memoriam: Brian Leyland-Jones, MB BS, PhD

National Foundation for Cancer Research
Business Announcement

June 20, 1949 – January 2026

The National Foundation for Cancer Research mourns the loss of Dr. Brian Leyland-Jones, a leading figure in global cancer research, a tireless patient advocate, and a cherished member of the NFCR family for more than two decades.

20-Jan-2026

 

To fight cancer, scientists customize cellular protein

University of Massachusetts Amherst
Peer-Reviewed Publication

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at the University of Massachusetts Amherst, could have applications beyond cancer to a wide range of immunological diseases, members of the interdisciplinary research team say. The work was published recently in the Journal of the American Cancer Society.

Journal

Journal of the American Chemical Society

20-Jan-2026

 

Targeted therapy shows promise against aggressive brain tumors, alliance trial finds

Alliance for Clinical Trials in Oncology
Peer-Reviewed Publication

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have specific genetic mutations. This primary analysis of Alliance A071401 is published in Nature Medicine.

Journal

Nature Medicine

Funder

National Clinical Trials Network, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Damon Runyon Cancer Research Foundation, Alexandra Dane

20-Jan-2026

Immunotherapy success could be predicted with new biomarkers

Wellcome Trust Sanger Institute
Peer-Reviewed Publication

Scientists pinpoint two cancer genes that when deleted, improve the vulnerability of tumour cells to immunotherapy. 

Journal

Cell Reports Medicine